Acceptance of the CP950 Sound Processor

Cochlear

Status: Completed

Conditions: Hearing Loss, Sensorineural

Treatments: Device: CP950 OTE Sound processor

Study type: Interventional

Funder types: Industry

Identifiers

NCT03613909

CLTD5591

Details and patient eligibility

About

Acceptance of CP950 sound processor with experienced CP810/CP910/CP920 BTE sound processor users.

Enrollment: 23 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Eighteen years of age or older
2. At least 6 months experience with a Nucleus 24 series or later implant in at least one implanted ear
3. At least 3 months experience with the CP810,CP920 or CP910 sound processor
4. Native speaker in the language used to assess speech perception performance
5. Willingness to participate in and to comply with all requirements of the protocol
6. Able to score 30% or more at +15 SNR with CI alone

Exclusion criteria

1. Unrealistic expectations on the part of the subject, regarding the possible benefits, risks and limitations that are inherent to the procedure and prosthetic device
2. Additional disabilities that would prevent participation in evaluations
3. Nucleus 22 Implant

Trial design

Primary purpose: Other

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

23 participants in 1 patient group

All participants

Experimental group

Description:

At least 6 months experience with a Nucleus 24 series or later implant in at least one implanted ear and at least 3 months experience with the CP810,CP920 or CP910 sound processor.

Treatment:

Device: CP950 OTE Sound processor